Citi analyst Daniel Grosslight raised the firm’s price target on Teladoc (TDOC) to $10.50 from $9.50 and keeps a Neutral rating on the shares as part of a Q3 earnings preview. Citi is “encouraged” by third-party data regarding Teladoc’s trends and believes BetterHelp’s results will surprise to the upside.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC: